Attached files
file | filename |
---|---|
10-K - ARRHYTHMIA RESEARCH 2009 10K - MICRON SOLUTIONS INC /DE/ | art200910k.htm |
EX-23.1 - EX23-1 AUDITORS CONSENT - MICRON SOLUTIONS INC /DE/ | exhibit23-1.htm |
EX-32.2 - EX32-2 CERTIFICATION OF CFO SEC906 SOX 2002 - MICRON SOLUTIONS INC /DE/ | exhibit32-2.htm |
EX-31.1 - EX31-1 CERTIFICATION OF CEO - MICRON SOLUTIONS INC /DE/ | exhibit31-1.htm |
EX-31.2 - EX31-1 CERTIFICATION OF CFO - MICRON SOLUTIONS INC /DE/ | exhibit31-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report on Form 10-K of Arrhythmia Research
Technology, Inc. (the “Company”) for the year ended December 31, 2009, as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
the undersigned President and Chief Executive Officer certifies, pursuant to 18
U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended;
and
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
March 10, 2010
/s/ James E.
Rouse
James E.
Rouse
President
and
Chief
Executive Officer